These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 395067

  • 21. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas.
    Drouin P, Rousselle D, Pointel JP, Voisin G, Stoltz JF, Clemens AH, Debry G.
    Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064
    [Abstract] [Full Text] [Related]

  • 22. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A, Granić M, Topić B, Skrabalo Z.
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS, Svendsen PA, Deckert T.
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [Abstract] [Full Text] [Related]

  • 25. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF, Beischer W, Thum C, Clemens AH.
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract] [Full Text] [Related]

  • 26. Use of an artificial endocrine pancreas in diabetic pregnancy.
    Tamás G, Bojta J, Báayai Z, Petrányi G, Szalay J.
    Horm Metab Res Suppl; 1979 May; (8):166-8. PubMed ID: 395075
    [Abstract] [Full Text] [Related]

  • 27. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R, Hepp KD, Mehnert H, Franetzki M.
    Horm Metab Res Suppl; 1979 May; (8):186-90. PubMed ID: 395077
    [Abstract] [Full Text] [Related]

  • 28. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS, Fisher ER, Kozak W, Bahl VK, Stephan T, Nolan S, Ahmad U.
    Behav Neuropsychiatry; 1979 May; 8(1-12):6-15. PubMed ID: 1052263
    [Abstract] [Full Text] [Related]

  • 29. [The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].
    Schatz H, Pfeiffer EF.
    MMW Munch Med Wochenschr; 1976 Apr 16; 118(16):485-92. PubMed ID: 818514
    [Abstract] [Full Text] [Related]

  • 30. A portable, Preprogrammable insulin infusion system with 16 rates.
    Kølendorf K, Bojsen J.
    Horm Metab Res Suppl; 1979 Apr 16; (8):65-6. PubMed ID: 395092
    [Abstract] [Full Text] [Related]

  • 31. [The "artificial endocrine pancreas": alternative to conventional insulin therapy].
    Hepp KD.
    Med Klin; 1981 Feb 13; 76(4):95-100, 70. PubMed ID: 7012567
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF, Thum C, Clemens AH.
    Horm Metab Res; 1974 Sep 13; 6(5):339-42. PubMed ID: 4607598
    [No Abstract] [Full Text] [Related]

  • 34. Significance of renormalization of blood glucose concentration in diabetes mellitus.
    Pfeiffer EF.
    Horm Metab Res Suppl; 1979 Sep 13; (8):2-8. PubMed ID: 395080
    [No Abstract] [Full Text] [Related]

  • 35. Technological problems of miniaturized insulin dosing devices and some approaches to clinical trials.
    Franetzki M, Prestele K, Kresse H.
    Horm Metab Res Suppl; 1979 Sep 13; (8):58-65. PubMed ID: 395091
    [Abstract] [Full Text] [Related]

  • 36. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
    Lenti G, Trovati M, Lorenzati R, Vitelli F, Tagliaferro V, Marocco A, Pagano G.
    Acta Diabetol Lat; 1980 Sep 13; 17(1):9-14. PubMed ID: 6106342
    [Abstract] [Full Text] [Related]

  • 37. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS, Fisher ER, Kozak W, Bahl VK, Stephan T, Nolan S, Ahmad U.
    PDM; 1976 Sep 13; 7(9-12)8(1-8):7-16. PubMed ID: 1052833
    [Abstract] [Full Text] [Related]

  • 38. [Effects of subcutaneous insulin infusions on the metabolic regulation in unstable diabetics].
    Keller U, Viollier E, Schwarz U, Girard J, Berger W.
    Schweiz Med Wochenschr; 1980 Nov 22; 110(47):1754-60. PubMed ID: 7006075
    [No Abstract] [Full Text] [Related]

  • 39. Continuous subcutaneous insulin infusion: a developing tool in diabetes research.
    Pickup JC, Keen H.
    Diabetologia; 1980 Jan 22; 18(1):1-4. PubMed ID: 6988262
    [No Abstract] [Full Text] [Related]

  • 40. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells.
    Horwitz DL.
    Horm Metab Res Suppl; 1979 Jan 22; (8):68-71. PubMed ID: 395093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.